Glaucoma is the leading cause of irreversible blindness worldwide. Minimally invasive surgeries are not efficacious at sustaining lower IOP while more effective implants (tube shunts) are invasive and carry greater post-operative risks.
VisiPlate is a nanoscale aqueous shunt implanted in the subconjunctival space.
Aids with identifying the nature and cause(s) of a clinical problem or illness
Increases the efficacy of a clinical process or procedure
Enables healing from or treatment of an illness or clinical problem
Records/shares data as on-going surveillance of a clinical problem, process or procedure